title: Erratum to: Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY.
authors.affiliation: Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
authors.forename: I
authors.initials: I
authors.lastname: Bernabeu
authors.affiliation: Hospital General Universitario de Alicante, Alicante, Spain. antonio.pico@goumh.umh.es.
authors.forename: A
authors.initials: A
authors.lastname: Pico
authors.affiliation: Hospital Universitario Virgen del Rocío, Seville, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Venegas
authors.affiliation: Hospital Universitario Puerta de Hierro - Majadahonda, Madrid, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Aller
authors.affiliation: Hospital Universitario La Paz, Madrid, Spain.
authors.forename: C
authors.initials: C
authors.lastname: Alvarez-Escolá
authors.affiliation: Hospital Regional Universitario de Málaga, Málaga, Spain.
authors.forename: J A
authors.initials: JA
authors.lastname: García-Arnés
authors.affiliation: Hospital Universitario de La Princesa, Madrid, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Marazuela
authors.affiliation: Pfizer Endocrine Care, Sollentuna, Sweden.
authors.forename: P
authors.initials: P
authors.lastname: Jonsson
authors.affiliation: Pfizer Medical Department, Madrid, Spain.
authors.forename: N
authors.initials: N
authors.lastname: Mir
authors.affiliation: Pfizer Medical Department, Madrid, Spain.
authors.forename: M García
authors.initials: MG
authors.lastname: Vargas